[HTML][HTML] Identification of 4-methylation driven genes based prognostic signature in thyroid cancer: an integrative analysis based on the methylmix algorithm
Z Chen, X Liu, F Liu, G Zhang, H Tu, W Lin… - Aging (Albany NY …, 2021 - ncbi.nlm.nih.gov
Thyroid cancer (TC) is known with a high rate of persistence and recurrence. We aimed to
develop a prognostic signature to monitor and assess the survival of TC patients. mRNA …
develop a prognostic signature to monitor and assess the survival of TC patients. mRNA …
[HTML][HTML] TMEM100 negatively regulated by microRNA‑106b facilitates cellular apoptosis by suppressing survivin expression in NSCLC
J Ma, T Yan, Y Bai, M Ye, C Ma, X Ma… - Oncology …, 2021 - spandidos-publications.com
Non‑small cell lung cancer (NSCLC) is a common malignant tumour. Nevertheless, the 5‑
year survival rate of NSCLC patients remains poor. Thus, identifying critical factors involved …
year survival rate of NSCLC patients remains poor. Thus, identifying critical factors involved …
Systems biology analysis to understand regulatory miRNA networks in lung cancer
M Kunz, A Pittroff, T Dandekar - Computational Cell Biology: Methods and …, 2018 - Springer
Lung cancer has currently the highest cancer-related mortality rate worldwide. MicroRNAs
(miRNAs) are small noncoding RNAs that play a fundamental role in gene expression and …
(miRNAs) are small noncoding RNAs that play a fundamental role in gene expression and …
[PDF][PDF] Blocking VRK2 suppresses pulmonary adenocarcinoma progression via ERK1/2/AKT signal pathway by targeting miR-145-5p.
Y Mu, WJ Liu, LY Bie, XQ Mu… - European Review for …, 2021 - europeanreview.org
OBJECTIVE: The incidence of pulmonary adenocarcinoma locates first in all the malignant
tumors in the world. At present, there are many diagnostic methods for pulmonary …
tumors in the world. At present, there are many diagnostic methods for pulmonary …
Identification of factors for the preoperative prediction of tumour subtype and prognosis in patients with T1 lung adenocarcinoma
WY Zhu, YK Zhang, Z Chai, X Hu, L Tan… - Disease …, 2016 - Wiley Online Library
Aims. Identification of factors that can predict the subtypes of lung adenocarcinoma
preoperatively is important for selecting the appropriate surgical procedure and for …
preoperatively is important for selecting the appropriate surgical procedure and for …
[HTML][HTML] Potential biomarkers for lung adenocarcinoma identified by integrative transcriptomics analysis
C KASAVİ - Biotech Studies, 2021 - dergipark.org.tr
Lung cancer is one of the most occurring and death-causing cancers worldwide. Despite the
progress, survival rate is still low due to the late diagnosis. The aim of this study is to develop …
progress, survival rate is still low due to the late diagnosis. The aim of this study is to develop …
[HTML][HTML] 甲基化在肺癌研究领域的相关进展
张少伟, 薛志强 - Chinese Journal of Lung Cancer, 2017 - ncbi.nlm.nih.gov
肺癌愈发成为威胁中国居民生命的恶性疾病, 其发病率持续攀升而治疗效果不尽如人意,
因此加强其早期诊断、 治疗、 预后等方面的研究至关重要。 以“不依赖DNA …
因此加强其早期诊断、 治疗、 预后等方面的研究至关重要。 以“不依赖DNA …
[PDF][PDF] Non-Invasive Biomarkers for Early Lung Cancer Detection. Cancers 2022, 14, 5782
Worldwide, lung cancer (LC) is the most common cause of cancer death, and any delay in
the detection of new and relapsed disease serves as a major factor for a significant …
the detection of new and relapsed disease serves as a major factor for a significant …
Progress of Epigenetic Methylation in Lung Cancer Research.
S Zhang, XUE Zhiqiang - Chinese Journal of Lung Cancer, 2017 - search.ebscohost.com
Lung cancer is becoming an increasing threat to Chinese residents and its incidence
continues to rise while the treatment effect is far from satisfactory. Hence, it is essential to …
continues to rise while the treatment effect is far from satisfactory. Hence, it is essential to …
Perfil de expressão de microRNAs e seus alvos moleculares em carcinoma pulmonar
CP Souza - 2016 - repositorio.unesp.br
Introdução: O câncer de pulmão é a principal causa de morte por câncer no mundo. Apesar
dos avanços nas estratégias de diagnóstico e o desenvolvimento de novas terapias com …
dos avanços nas estratégias de diagnóstico e o desenvolvimento de novas terapias com …